BTMD
biote Corp.NASDAQHealthcare$1.59+3.14%ClosedMarket Cap: $70.1M
As of 2026-04-06
Valuation
P/E (TTM)
2.59
PEG
0.00
P/B
-0.86
P/S
0.38
EV/EBITDA
4.03
DCF Value
$5.28
FCF Yield
41.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.5%
Operating Margin
18.5%
Net Margin
14.1%
ROE
-35.3%
ROA
25.1%
ROIC
43.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $46.4M | 68.0% | $6.8M | $2.0M | $0.06 | — |
| FY 2025 | $192.2M | 71.5% | $35.6M | $27.0M | $0.74 | — |
| Q3 2025 | $48.0M | 71.8% | $8.3M | $8.2M | $0.22 | — |
| Q2 2025 | $48.9M | 71.6% | $10.8M | $3.2M | $0.10 | — |
| Q1 2025 | $49.0M | 74.3% | $9.7M | $13.7M | $0.37 | — |
| Q4 2024 | $49.8M | 71.3% | $2.8M | $3.7M | $0.10 | — |
| FY 2024 | $197.2M | 70.5% | $31.6M | $3.2M | $0.09 | — |
| Q3 2024 | $51.4M | 70.5% | $12.2M | $10.7M | $0.33 | — |
| Q2 2024 | $49.2M | 68.9% | $6.2M | $-6.3M | $-0.19 | — |
| Q1 2024 | $46.8M | 71.3% | $10.4M | $-4.2M | $-0.06 | — |
| Q4 2023 | $45.7M | 69.4% | $5.5M | $7.7M | $0.12 | — |
| FY 2023 | $185.4M | 68.8% | $28.7M | $3.3M | $0.13 | — |